Simvastatin Rosemont Oral Suspension
Simvastatin is an oral liquid medicine used to treat cardiovascular difficulties.
Simvastatin Oral Suspension is indicated for the following:
Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.
Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid-lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.
Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy (see section 5.1 of the EMC).
Summary of Product Characteristics
Read this summary of product characteristics for further information about Simvastatin Rosemont Oral Suspension. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Simvastatin Rosemont Oral Suspension, what it’s used for and possible side effects. Click below to navigate to the EMC.
Simvastatin Rosemont Oral Suspension
Click here for Audio Version | |
Flavour | Strawberry |
Storage Conditions | Do not store above 25°C |
Sucrose Free | |
Shelf Life (Closed Bottle/Open Bottle) | 12 months / 1 month |
PIP Code | 115-5043 |
EAN Code | 05016119000096 |
Sodium Levels | Essentially sodium-free |
Ethanol Concentration | None |
Downloads
Click here for Audio Version | |
Flavour | Lime |
Storage Conditions | Do not store above 25°C |
Sucrose Free | |
Shelf Life (Closed Bottle/Open Bottle) | 24 months / 1 month |
PIP Code | 115-5050 |
EAN Code | 05016119000065 |
Sodium Levels | Essentially sodium-free |
Ethanol Concentration | None |
Downloads
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.